Microbion Corporation Initiates Phase 2 Clinical Study Evaluating Topical Pravibismane Treatment of Diabetic Foot Infections

Phase 2 study assesses safety and efficacy of topical pravibismane in subjects suffering from moderate infections associated with chronic diabetic foot ulcers BOZEMAN, Mont. and VANCOUVER, BC, March 9, 2023 /PRNewswire/ – Microbion Corporation today announced that a Phase 2, randomized,…

Leave a Reply

Your email address will not be published. Required fields are marked *